Search research articles
Contact Us
Filters
Showing results (151-160 of 259) with videos related to
Page
of 26
Sort By:
Molecular Genetics and Metabolism
|
September 5, 2002
Prosaposin: threshold rescue and analysis of the "neuritogenic" region in transgenic mice
Ying Sun, Xiaoyang Qi, David P Witte, et al.
Plos One
|
October 15, 2013
Gaucher disease: transcriptome analyses using microarray or mRNA sequencing in a Gba1 mutant mouse model treated with velaglucerase alfa or imiglucerase
Nupur Dasgupta, You-Hai Xu, Sunghee Oh, et al.
Journal of Clinical Pharmacology
|
January 7, 2006
The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase
Reza Khosravan, Brian A Grabowski, Michael D Mayer, et al.
AJR. American Journal of Roentgenology
|
November 1, 1986
Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy
G Hermann, J Goldblatt, R N Levy, et al.
Biochimica Et Biophysica Acta
|
August 25, 2009
Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors
Anton I Rosenbaum, Madalina Rujoi, Amy Y Huang, et al.
Pediatric Research
|
February 1, 1996
Turnover and distribution of intravenously administered mannose-terminated human acid beta-glucosidase in murine and human tissues
Y H Xu, E Ponce, Y Sun, et al.
Journal of Cellular Biochemistry
|
May 16, 2008
Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells
S Koochekpour, T-J Lee, Y Sun, et al.
The Journal of Biological Chemistry
|
April 15, 1994
Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry
S Miao, J D McCarter, M E Grace, et al.
American Journal of Medical Genetics
|
July 1, 1985
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients
G A Grabowski, J Goldblatt, T Dinur, et al.
American Journal of Hematology
|
October 26, 2005
Guidance on the use of miglustat for treating patients with type 1 Gaucher disease
Neal J Weinreb, John A Barranger, Joel Charrow, et al.
Page
of 26
Search research articles
Search
Showing results (151-160 of 259) with videos related to
Sort By:
Page
of 26
Molecular Genetics and Metabolism
|
September 5, 2002
Prosaposin: threshold rescue and analysis of the "neuritogenic" region in transgenic mice
Ying Sun, Xiaoyang Qi, David P Witte, et al.
Plos One
|
October 15, 2013
Gaucher disease: transcriptome analyses using microarray or mRNA sequencing in a Gba1 mutant mouse model treated with velaglucerase alfa or imiglucerase
Nupur Dasgupta, You-Hai Xu, Sunghee Oh, et al.
Journal of Clinical Pharmacology
|
January 7, 2006
The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase
Reza Khosravan, Brian A Grabowski, Michael D Mayer, et al.
AJR. American Journal of Roentgenology
|
November 1, 1986
Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy
G Hermann, J Goldblatt, R N Levy, et al.
Biochimica Et Biophysica Acta
|
August 25, 2009
Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors
Anton I Rosenbaum, Madalina Rujoi, Amy Y Huang, et al.
Pediatric Research
|
February 1, 1996
Turnover and distribution of intravenously administered mannose-terminated human acid beta-glucosidase in murine and human tissues
Y H Xu, E Ponce, Y Sun, et al.
Journal of Cellular Biochemistry
|
May 16, 2008
Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells
S Koochekpour, T-J Lee, Y Sun, et al.
The Journal of Biological Chemistry
|
April 15, 1994
Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry
S Miao, J D McCarter, M E Grace, et al.
American Journal of Medical Genetics
|
July 1, 1985
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients
G A Grabowski, J Goldblatt, T Dinur, et al.
American Journal of Hematology
|
October 26, 2005
Guidance on the use of miglustat for treating patients with type 1 Gaucher disease
Neal J Weinreb, John A Barranger, Joel Charrow, et al.
Page
of 26